Utility of Promoter Hypermethylation for Differentiating Malignant and Benign Effusions in Liquid-Based Cytology Specimens
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Background : Making the cytologic differentiation between benign and malignant effusions can be difficult. Because promoter hypermethylation of tumor suppressor genes is a frequent epigenetic event in many human cancers, it could serve as a marker for the diagnosis of cancer. The aim of this study was to investigate the feasibility of detecting promoter hypermethylation as a diagnostic tool with using liquid-based cytology samples for differentiating between malignant and benign effusions. Methods : A multiplex, nested, methylation-specific polymerase chain reaction analysis was used to examine promoter methylation of 4 genes (retinoic acid receptor-β [RAR-β], adenomatous polyposis coli [APC], Twist and high in normal-1 [HIN-1]) in malignant (n = 85) and benign (n = 31) liquid-based cytology samples. Results : The frequencies of hypermethylation of RAR-β‚ APC, Twist and HIN-1 were significantly higher in the malignant effusions than in the benign effusions (p < 0.001 for each). On the receiver-operating characteristic analysis, the area under the curve (AUC) for APC was the greatest. The AUC for the best two-gene combination (APC/HIN-1) was not statistically different from the AUC for the best individual tumor suppressor gene (APC). Conclusions : This study suggests that promoter methylation analysis on residual liquid-based effusion samples may be a feasible approach to detect malignant effusions, and that APC is the best marker for differentiating between malignant and benign effusions.
Abstract
Background : Making the cytologic differentiation between benign and malignant effusions can be difficult. Because promoter hypermethylation of tumor suppressor genes is a frequent epigenetic event in many human cancers, it could serve as a marker for the diagnosis of cancer. The aim of this study was to investigate the feasibility of detecting promoter hypermethylation as a diagnostic tool with using liquid-based cytology samples for differentiating between malignant and benign effusions. Methods : A multiplex, nested, methylation-specific polymerase chain reaction analysis was used to examine promoter methylation of 4 genes (retinoic acid receptor-β [RAR-β], adenomatous polyposis coli [APC], Twist and high in normal-1 [HIN-1]) in malignant (n = 85) and benign (n = 31) liquid-based cytology samples. Results : The frequencies of hypermethylation of RAR-β‚ APC, Twist and HIN-1 were significantly higher in the malignant effusions than in the benign effusions (p < 0.001 for each). On the receiver-operating characteristic analysis, the area under the curve (AUC) for APC was the greatest. The AUC for the best two-gene combination (APC/HIN-1) was not statistically different from the AUC for the best individual tumor suppressor gene (APC). Conclusions : This study suggests that promoter methylation analysis on residual liquid-based effusion samples may be a feasible approach to detect malignant effusions, and that APC is the best marker for differentiating between malignant and benign effusions.
참고문헌 (26)
- Fenton KN, "Diagnosis and management of malignant pleural effusions", Am J Surg, 170, pp.69~74 (1995)
- Chernow B, "Carcinomatous involvement of the pleura:an analysis of 96 patients", Am J Med, 63, pp.695~702 (1977)
- van de Molengraft FJ, "Survival of patients with malignancy-associated effusions", Acta Cytol, 33, pp.911~916 (1989)
- Mohanty SK, "Serous effusions:diagnosis of malignancy beyond cytomorphology:an analytic review", Postgrad Med J, 79, pp.569~574 (2003)
- Pereira TC, "The diagnosis of malignancy in effusion cytology:a pattern recognition approach", Adv Anat Pathol, 13, pp.174~184 (2006)
- Gabriel C, "Use of liquid-based cytology in serous fluids:a comparison with conventional cytopreparatory techniques", Acta Cytol, 48, pp.825~835 (2004)
- Lee JS, "Diagnostic value of p53 protein and flow cytometric DNA analysis in the study of serous effusions", Acta Cytol, 41, pp.1719~1725 (1997)
- Wajed SA, "DNA methylation:an alternative pathway to cancer", Ann Surg, 234, pp.10~20 (2001)
- Wisman GB, "Assessment of gene promoter hypermethylation for detection of cervical neoplasia", Int J Cancer, 119, pp.1908~1914 (2006)
- Belinsky SA, "Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort", Cancer Res, 66, pp.3338~3344 (2006)
- Cairns P, "Gene methylation and early detection of genitourinary cancer:the road ahead", Nat Rev Cancer, 7, pp.531~543 (2007)
- Palmisano WA, "Predicting lung cancer by detecting aberrant promoter methylation in sputum", Cancer Res, 60, pp.5954~5958 (2000)
- Benlloch S, "Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion", Cancer, 107, pp.1859~1865 (2006)
- Ibanez de Caceres I, "Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum,plasma,and peritoneal fluid from ovarian cancer patients", Cancer Res, 64, pp.6476~6481 (2004)
- Brock MV, "Can we improve the cytologic examination of malignant pleural effusions using molecular analysis?", Ann Thorac Surg, 80, pp.1241~1247 (2005)
- Katayama H, "Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion", Int J Cancer, 120, pp.2191~2195 (2007)
- 장세진, "체액세포 도말검사에서 메틸화 이상이 악성 중피종 진단의 부가적인 분자 표지자로서의 기능", 대한세포병리학회지, 19(2), pp.126~135 (2008), 대한세포병리학회
- Chen ML, "Epigenetic changes in tumor suppressor genes,P15,P16,APC-3 and E-cadherin in body fluid", Kaohsiung J Med Sci, 23, pp.498~503 (2007)
- Tsou JA, "Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma", Mol Cancer, 6, pp.70~ (2007)
- Esteller M, "Analysis of adenomatous poly-posis coli promoter hypermethylation in human cancer", Cancer Res, 60, pp.4366~4371 (2000)
- Lee JS, "A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young,ER,PR-negative breast cancer in Korean women", Cancer Biol Ther, 6, pp.1114~1120 (2007)
- House MG, "Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms(IPMN)of the pancreas", Carcinogenesis, 24, pp.193~198 (2003)
- Fackler MJ, "DNA methylation of RASS F1A,HIN-1,RAR-beta,Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma", Int J Cancer, 107, pp.970~975 (2003)
- Fackler MJ, "Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer", Cancer Res, 64, pp.4442~4452 (2004)
- Gustafson KS, "DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens:an approach that utilizes receiver-operating characteristic analysis", Cancer, 102, pp.259~268 (2004)
- Toyooka S, "Smoke exposure,histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer", Int J Cancer, 103, pp.153~160 (2003)